Hims & Hers Health Future Growth
Future criteria checks 4/6
Hims & Hers Health is forecast to grow earnings and revenue by 40.5% and 18.4% per annum respectively while EPS is expected to grow by 43% per annum.
Key information
40.5%
Earnings growth rate
43.0%
EPS growth rate
Healthcare earnings growth | 17.1% |
Revenue growth rate | 18.4% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 17 Jun 2024 |
Recent future growth updates
Recent updates
Hims & Hers: Buy The Dip To Catch The Next Rip
Jun 24Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge
Jun 19Hims & Hers: The Undervalued Gem Poised For Growth
Jun 18Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable
Jun 10Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment
May 31Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead
May 21Hims & Hers Health: An Unforced Error
May 06Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing
May 04Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry
Apr 24Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation
Apr 05Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock
Mar 21Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health
Mar 12Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%
Feb 28Hims & Hers: Turning The Profitability Corner And Returning 28%
Feb 25Hims & Hers Health: No Clear Moat Besides First Mover Advantage
Jan 23Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple
Jan 10Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)
Jan 07Hims & Hers Health Q3: The Cheapest Growth Stock Around
Dec 14Hims & Hers Health: What Would The Author Of 100 Baggers Say?
Nov 30Hims & Hers: The Most Undervalued Small Cap Stock I See
Nov 08Hims & Hers: A Promising Company With Resolvable Challenges
Nov 02Hims & Hers: Specialization Is The Secret To Great Growth
Oct 25Hims & Hers Health: Can't Get Much Better
Sep 25The Market Is Wrong On Hims & Hers Health
Sep 18Hims & Hers: The Current Weakness Creates A Buying Opportunity
Aug 15Hims & Hers Health: Giving Investors Another Bite At The Apple
Aug 01Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues
Jul 21Hims & Hers Health: Expect Strong EBITDA Growth As Revenue Growth Remains Strong
Jul 13Hims & Hers Health: Double-Edged Sword
Jul 02Hims & Hers: More Transparency Could Help The Stock
Jun 09Hims & Hers Health (NYSE:HIMS) Is In A Strong Position To Grow Its Business
Apr 19Are Investors Undervaluing Hims & Hers Health, Inc. (NYSE:HIMS) By 41%?
Mar 30Him & Hers Health Q4 2022 Earnings Preview
Feb 24Hims & Hers spikes as Jefferies upgrades ahead of 2023 guidance
Feb 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,883 | 109 | N/A | 289 | 9 |
12/31/2025 | 1,547 | 72 | 141 | 200 | 13 |
12/31/2024 | 1,229 | 41 | 64 | 145 | 13 |
3/31/2024 | 959 | -2 | 52 | 90 | N/A |
12/31/2023 | 872 | -24 | 47 | 73 | N/A |
9/30/2023 | 793 | -36 | 27 | 45 | N/A |
6/30/2023 | 711 | -47 | 12 | 26 | N/A |
3/31/2023 | 616 | -59 | -6 | 2 | N/A |
12/31/2022 | 527 | -66 | -34 | -27 | N/A |
9/30/2022 | 444 | -86 | -29 | -23 | N/A |
6/30/2022 | 374 | -83 | -51 | -45 | N/A |
3/31/2022 | 321 | -73 | -43 | -38 | N/A |
12/31/2021 | 272 | -108 | -39 | -34 | N/A |
9/30/2021 | 229 | -82 | -36 | -32 | N/A |
6/30/2021 | 196 | -72 | -17 | -12 | N/A |
3/31/2021 | 171 | -63 | -18 | -13 | N/A |
12/31/2020 | 149 | -18 | -7 | -2 | N/A |
9/30/2020 | 132 | -25 | -16 | -13 | N/A |
6/30/2020 | 112 | -38 | -43 | -41 | N/A |
3/31/2020 | 95 | -58 | -62 | -60 | N/A |
12/31/2019 | 83 | -72 | -77 | -75 | N/A |
12/31/2018 | 27 | -75 | -57 | -57 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HIMS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: HIMS is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: HIMS is expected to become profitable in the next 3 years.
Revenue vs Market: HIMS's revenue (18.4% per year) is forecast to grow faster than the US market (8.6% per year).
High Growth Revenue: HIMS's revenue (18.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HIMS's Return on Equity is forecast to be high in 3 years time